You've changed. And your care plan should too.

Please provide your email address to receive an email when new articles are posted on . Patients with systemic lupus with a history of skin rashes are likely to have high interferon levels. This ...

NEW YORK, Dec. 11, 2025 /PRNewswire/ -- Today, the Lupus Research Alliance, the world's largest private funder of lupus research, announced the first recipients of the Mechanistic Clinical Award. This ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on January 22, 2026, Health Canada has approved Gazyva® ...

Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed ...

The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, ...

There are a few to keep in mind.

Upper Limb Dysfunction Linked to Poor Quality of Life in SLE In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to ...

Add Yahoo as a preferred source to see more of our stories on Google. For many women living with lupus, the hardest part of the disease isn’t learning the diagnosis, it’s learning how much suffering ...

Add Yahoo as a preferred source to see more of our stories on Google. Dealing with unexplained symptoms when you’re undergoing treatment for lupus can make you question what’s going on in your body.